Health Affairs' Jeff Byers welcomes Troyen A. Brennan of Harvard T.H. Chan School of Public Health and former CMO at CVS ...

With 2026 rates already set and consumers starting to learn of premium increases, delays in extending the PTC enhancements ...

Understanding the needs of high-need, high-cost community-based beneficiaries, including homebound status, will help Medicare ...

When implemented in state employee health plans, reference-based hospital price caps have the potential to save states money ...

The final guidance for the 2028 cycle of the Medicare drug price negotiation reflects CMS’s continued effort to balance ...

Outbreaks of mpox have now been reported in more than a dozen countries across Africa, revealing a continent-wide surge just ...

We contrast the differences between the traditional model of vaccine federalism and the emerging paradigms introduced by the ...

As states pursue policies to slow cost growth, they must apply greater scrutiny of vertical integration ...

Health Affairs' Rob Lott interviews Tris Dyson, Founder of Challenge Works on his efforts in cultivating challenge prizes as ...

Additional federal restrictions on mifepristone—whether imposed by the courts or the Trump administration in the future—would ...

Switching to Medicare Advantage from fee-for-service (and vice versa) may ultimately restrict access to novel medications and ...

By quantifying the growth and distribution of outpatient facility fees, states such as Colorado, Maine, Connecticut, and ...